Cancer-free future – World Cancer Day
This World Cancer Day, WHO urges all governments to act now to detect breast cancer earlier, diagnose it faster, treat it better and give everyone
Prostate Cancer
Prostate cancer is a malignancy of one of the major male sex glands, in which cells of the prostate become abnormal and start to grow uncontrollably, forming tumors.
Provenge – Sipuleucel-T may have added benefit in prostate cancer
Sipuleucel-T in prostate cancer: Indication of added benefit – Sipuleucel-T (trade name Provenge) has been approved since September 2014 for men with metastatic prostate cancer who have few or no symptoms and do not yet require chemotherapy. In the dossier assessment conducted by the German Institute for Quality and Efficiency in Health Care (IQWiG) in January 2015, no added benefit could be derived for sipuleucel-T.
Cigarette smoking may cause more deaths than currently estimated
Cigarette smoking is even more deadly than you think — US Smoking deaths may be underestimated: Study – A new study suggests that current estimates significantly underestimate the number of Americans who die from cigarette smoking. The Surgeon General estimates that each year, smoking kills about 480,000 Americans.
ADT with docetaxel extends survival in metastatic prostate cancer
Drug Combination Extends Survival by More Than a Year in Metastatic Prostate Cancer – Men with newly diagnosed metastatic, hormone-sensitive prostate cancer lived more than a year longer when they received a chemotherapy drug docetaxel as initial treatment instead of waiting to for the disease to become resistant to hormone-blockers.
Prostate chronic inflammation increases prostate cancer risk
Chronic inflammation may be linked to aggressive prostate cancer — Chronic inflammation linked to ‘high-grade’ prostate cancer – Men who show signs of chronic inflammation in non-cancerous prostate tissue may have nearly twice the risk of actually having prostate cancer than those with no inflammation.
Melatonin may lower advanced prostate cancer risk
Melatonin may lower prostate cancer risk – Higher levels of melatonin, a hormone involved in the sleep-wake cycle, may suggest decreased risk for developing advanced prostate cancer. Melatonin is a hormone that is produced exclusively at night in the dark and is an important output of the circadian rhythm, or the body’s inherent 24-hour clock.
Grapes and red wine may help to treat multiple types of cancer
Compound in grapes, red wine could help treat multiple types of cancer, study finds – A recent study by a University of Missouri researcher shows that resveratrol, a compound found in grape skins and red wine, can make certain tumor cells more susceptible to radiation treatment.
Prostate cancer – A change in circulating tumor cells detection has high potential in the prediction
Prostate cancer: A change in circulating tumor cells detection has high potential in the prediction – A new study reveals that in the prediction of treatment outcome for castration-resistant prostate cancer, a change in circulating tumour cells detection might be more accurate than the change in prostate-specific antigen levels.
Androgen deprivation therapy for prostate cancer may increase kidney injury risk
Use of ADT For Treatment of Prostate Cancer Linked With Increased Risk of Kidney Injury – Androgen deprivation therapy (ADT) for nonmetastatic prostate cancer was associated with a significantly increased risk of acute kidney injury, according to a study that included more than 10,000 men published in JAMA.
Omega 3 and fish oil supplements may increase prostate cancer risk
Study confirms link between omega-3 fatty acids and increased prostate cancer risk — Consumption of fatty fish and fish-oil supplements linked to 71 percent higher risk – A second large, prospective study by scientists at Fred Hutchinson Cancer Research Center has confirmed the link between high blood concentrations of omega-3 fatty acids and an increased risk of prostate cancer.